External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Cardiovascular ESC 2025
Roche and Genentech at

ESC 2025

August 29 - September 01
Madrid, Spain / Virtual (Hybrid)
escardio.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:30 PM
Duration 10mins Madrid
KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
Neha Pagidipati
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:15 PM
Duration 45mins Madrid, Spain
Impact of Zilebesiran, an Investigational RNA Interference Therapeutic Targeting Hepatic Angiotensinogen, on Renin–Angiotensin System Biomarkers in Patients with Mild-to-Moderate Hypertension
Michael Weber
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:45 PM
Duration 60mins Madrid, Spain
Establishing reference values in healthy participants for a next generation cardiac troponin T high-sensitivity assay - the REF-TSIX global reference study
Lori B. Daniels
Cardiovascular | Acute Coronary Syndrome

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.